Tacrolimus and cyclosporine have differential effects on the risk of development of bronchiolitis obliterans syndrome: results of a prospective, randomized international trial in lung transplantation.
Related Research units
Abstract
Chronic lung allograft dysfunction, which manifests as bronchiolitis obliterans syndrome (BOS), is recognized as the primary cause of morbidity and mortality after lung transplantation. In this study we assessed the efficacy and safety of two de novo immunosuppression protocols to prevent BOS.
Bibliographical data
| Original language | English |
|---|---|
| Article number | 8 |
| ISSN | 1053-2498 |
| Publication status | Published - 2012 |
| pubmed | 22554673 |
|---|
